Louvain-la-Neuve, 14th January 2025 Minakem has been manufacturing the Fulvestrant Active Pharmaceutical Ingredient (API), used to treat certain
Minafin Group appoints Olivier Ubrich as CEO of Health Chemistry Division
Louvain-la-Neuve, Belgium – September 5th, 2024 – The Minafin Group, a leading developer and producer of fine chemicals, today announced
The EDQM has validated the updated CEP of Vinorelbine of Minakem, sole manufacturer in Europe
Louvain-la-Neuve, June 19th, 2024 – Vinorelbine is an important drug substance used to treat breast and lung cancers. Minakem is the sole
Reshoring: Minakem Canada is manufacturing steroid APIs in a brand-new production unit
Minakem’s investment in a new production unit in Lassalle, Montreal, for corticosteroid APIs reflects the company’s recognition
The ‘Made in Canada’ label for API manufacturing is garnering increasing interest in the pharmaceutical industry
Montreal, April 8th, 2024 – The COVID-19 pandemic has prompted North America and Europe to reconsider the feasibility of slightly rebalancing
Minakem (Dunkerque site) Earns Gold Medal from EcoVadis for Sustainability Performance
EcoVadis Rating validates Minakem’s business sustainability commitments and performance Minakem announced today that it has achieved a Gold
Purification of your small molecules by HPLC, from laboratory to industrial scale
Reach Separations and Minakem have decided to establish a collaboration to offer the full range of service to purify your molecules by HPLC
Minafin nomme Sébastien Poncet Directeur Général de Minakem Génériques et & Nouvelles Thérapies
L‘arrivée de Sébastien Poncet à la tête du centre de profit Minakem Génériques permettra de valoriser le potentiel de croissance de